Clinical research in Iraq presents both opportunities and regulatory considerations. As the pharmaceutical sector develops, understanding the local requirements for conducting clinical trials is important for companies planning research activities in the country.
Regulatory Submissions
Clinical trials in Iraq require regulatory approval from the Ministry of Health. The submission process includes a detailed protocol, investigator qualifications, informed consent documents, and supporting safety data. Companies should allow adequate time for the review process.
Ethics Committee Review
All clinical research involving human subjects must receive approval from an ethics committee. The application should include the study protocol, patient information sheets, informed consent forms, and investigator CVs. Ethics review focuses on patient safety, scientific validity, and informed consent procedures.
Good Clinical Practice
Clinical trials should be conducted in accordance with Good Clinical Practice (GCP) guidelines. GCP provides the framework for ensuring that clinical data is credible and that the rights, safety, and wellbeing of trial participants are protected.
Documentation and Oversight
Proper documentation is critical throughout the trial lifecycle. This includes maintaining the Trial Master File, recording adverse events, tracking protocol deviations, and preparing study reports. Ongoing oversight ensures compliance with the approved protocol and applicable regulations.
PKCS provides clinical research support services, including regulatory submissions, ethics committee applications, GCP guidance, and study coordination for companies conducting trials in Iraq. Contact us to discuss your clinical research needs.